Screening of phytochemicals as potential anti-breast cancer agents targeting HER2: an in-silico approach

References

• Aertgeerts, K., Skene, R., Yano, J., Sang, B.-C., Zou, H., Snell, G., Jennings, A., Iwamoto, K., Habuka, N., Hirokawa, A., Ishikawa, T., Tanaka, T., Miki, H., Ohta, Y., & Sogabe, S. (2011). Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein. The Journal of Biological Chemistry, 286(21), 18756–18765. https://doi.org/10.1074/jbc.M110.206193
   PubMed Web of Science ®Google Scholar
• Aftimos, P., Azim, H. A., & Sotiriou, C. (2018). Molecular biology of breast cancer. In W. B. Coleman & G. J. Tsongalis (Eds.), Molecular pathology (pp. 569–588). Elsevier. https://doi.org/10.1016/B978-0-12-802761-5.00026-2
   Google Scholar
• Amir, E., Ocaña, A., Seruga, B., Freedman, O., & Clemons, M. (2010). Lapatinib and HER2 status: Results of a meta-analysis of randomized phase III trials in metastatic breast cancer. Cancer Treatment Reviews, 36(5), 410–415. https://doi.org/10.1016/j.ctrv.2009.12.012
   PubMed Web of Science ®Google Scholar
• Banerjee, P., Eckert, A., Schrey, A., & Preissner, R. (2018). ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 46(W1), W257–W263. https://doi.org/10.1093/nar/gky318
   PubMed Web of Science ®Google Scholar
• Bartsch, R., Wenzel, C., & Steger, G. G. (2007). Trastuzumab in the management of early and advanced stage breast cancer. Biologics: Targets & Therapy, 1(1), 19–31.
   PubMedGoogle Scholar
• Benson, J. R., & Jatoi, I. (2012). The global breast cancer burden. Future Oncology (London, England), 8(6), 697–702. https://doi.org/10.2217/fon.12.61
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/10.1063/1.448118
   Web of Science ®Google Scholar
• Bhardwaj, V. K., & Purohit, R. (2020). A new insight into protein-protein interactions and the effect of conformational alterations in PCNA. International Journal of Biological Macromolecules, 148, 999–1009. https://doi.org/10.1016/j.ijbiomac.2020.01.212
   PubMed Web of Science ®Google Scholar
• Bhat, R., & Houghton, M. (2018). A human cardiomyocyte cell-line expressing hERG: An improved system for testing drug-associated hERG blocking and cardiotoxicity. Journal of Pharmacological and Toxicological Methods, 93, 114. https://doi.org/10.1016/j.vascn.2018.01.391
   Web of Science ®Google Scholar
• Biovia. (2017). Discovery Studio Visualizer [Computer software]. https://discover.3ds.com/discovery-studio-visualizer-download
   Google Scholar
• Bourne, Y., Taylor, P., Radić, Z., & Marchot, P. (2003). Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site. The EMBO Journal, 22(1), 1–12. https://doi.org/10.1093/emboj/cdg005
   PubMed Web of Science ®Google Scholar
• Bulusu, G., & Desiraju, G. R. (2020). Strong and weak hydrogen bonds in protein–ligand recognition. Journal of the Indian Institute of Science, 100(1), 31–41. https://doi.org/10.1007/s41745-019-00141-9
   Web of Science ®Google Scholar
• Cunningham, M. E., Stephens, R. M., Kaplan, D. R., & Greene, L. A. (1997). Autophosphorylation of activation loop tyrosines regulates signaling by the TRK nerve growth factor receptor. The Journal of Biological Chemistry, 272(16), 10957–10967. https://doi.org/10.1074/jbc.272.16.10957
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717–42717. https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• de Carvalho, M., Daniel, J., Alves, C., Grivicich, I., & da Rocha, A. (2007). Antitumor activity of biflavonoids from Ouratea and Luxemburgia on human cancer cell lines. Indian Journal of Pharmacology, 39(4), 184. https://doi.org/10.4103/0253-7613.36536
   Web of Science ®Google Scholar
• Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). A smooth particle mesh Ewald method. The Journal of Chemical Physics, 103(19), 8577–8593. https://doi.org/10.1063/1.470117
   Web of Science ®Google Scholar
• Eswar, N., Webb, B., Marti‐Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M., Pieper, U., & Sali, A. (2006). Comparative protein structure modeling using modeller. Current Protocols in Bioinformatics, 15(1), 5.6.1–5.6.30. https://doi.org/10.1002/0471250953.bi0506s15
   Google Scholar
• Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., Liu, B., Lei, Y., Du, S., Vuppalapati, A., Luu, H. H., Haydon, R. C., He, T.-C., & Ren, G. (2018). Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes & Diseases, 5(2), 77–106. https://doi.org/10.1016/j.gendis.2018.05.001
   PubMed Web of Science ®Google Scholar
• Finch, A., & Pillans, P. (2014). P-glycoprotein and its role in drug-drug interactions. Australian Prescriber, 37(4), 137–139. https://doi.org/10.18773/austprescr.2014.050
   Google Scholar
• Furrer, D. (2018). The human epidermal growth factor receptor 2 (HER2) as a prognostic and predictive biomarker: Molecular insights into HER2 activation and diagnostic implications. In Claudie Paquet, Caroline Diorio, & Guy-Joseph Lemamy (Eds.), Cancer prognosis (p. 2). IntechOpen. https://doi.org/10.5772/intechopen.78271
   Google Scholar
• Geyer, C. E., Forster, J., Lindquist, D., Chan, S., Romieu, C. G., Pienkowski, T., Jagiello-Gruszfeld, A., Crown, J., Chan, A., Kaufman, B., Skarlos, D., Campone, M., Davidson, N., Berger, M., Oliva, C., Rubin, S. D., Stein, S., & Cameron, D. (2006). Lapatinib plus capecitabine for HER2-positive advanced breast cancer. New England Journal of Medicine, 355(26), 2733–2743. https://doi.org/10.1056/NEJMoa064320
   PubMed Web of Science ®Google Scholar
• GLOBOCAN. (2020). 900 world fact sheets. Incidence, mortality and prevalence by cancer site 2020. https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf
   Google Scholar
• Guarneri, V., Lenihan, D. J., Valero, V., Durand, J.-B., Broglio, K., Hess, K. R., Michaud, L. B., Gonzalez-Angulo, A. M., Hortobagyi, G. N., & Esteva, F. J. (2006). Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: The M.D. Anderson Cancer Center experience. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 24(25), 4107–4115. https://doi.org/10.1200/JCO.2005.04.9551
   PubMed Web of Science ®Google Scholar
• Guex, N., & Peitsch, M. C. (1997). SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis, 18(15), 2714–2723. https://doi.org/10.1002/elps.1150181505
   PubMed Web of Science ®Google Scholar
• Gutierrez, C., & Schiff, R. (2011). HER2: Biology, detection, and clinical implications. Archives of Pathology & Laboratory Medicine, 135(1), 55–62. https://doi.org/10.1043/2010-0454-RAR.1 https://doi.org/10.5858/2010-0454-RAR.1
   PubMed Web of Science ®Google Scholar
• Halgren, T. A. (1996). Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. Journal of Computational Chemistry, 17(5–6), 490–519. https://doi.org/10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P
   Web of Science ®Google Scholar
• Halliday, D., Resnick, R., & Walker, J. (2013). Fundamentals of Physics Extended (10th ed.). Wiley.
   Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Web of Science ®Google Scholar
• Hsu, J. L., & Hung, M. C. (2016). The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer. Cancer Metastasis Reviews, 35(4), 575–588. https://doi.org/10.1007/s10555-016-9649-6
   PubMed Web of Science ®Google Scholar
• Huang, J., & MacKerell, A. D. (2013). CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data. Journal of Computational Chemistry, 34(25), 2135–2145. https://doi.org/10.1002/jcc.23354
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD – Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38.
   PubMedGoogle Scholar
• Iqbal, N., & Iqbal, N. (2014). Human epidermal growth factor receptor 2 (HER2) in cancers: Overexpression and therapeutic implications. Molecular Biology International, 2014, 852748. https://doi.org/10.1155/2014/852748
   PubMedGoogle Scholar
• Jacobs, E. C. (2018). Potential therapeutic effects of phytochemicals and medicinal herbs for cancer prevention and treatment. Archives of General Internal Medicine, 02(03), 44-48. https://doi.org/10.4066/2591-7951.1000058
   Google Scholar
• Joensuu, H., Isola, J., Lundin, M., Salminen, T., Holli, K., Kataja, V., Pylkkänen, L., Turpeenniemi-Hujanen, T., von Smitten, K., & Lundin, J. (2003). Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: A nationwide population-based study. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 9(3), 923–930.
   PubMed Web of Science ®Google Scholar
• Kellis, J. T., Nyberg, K., Sali, D., & Fersht, A. R. (1988). Contribution of hydrophobic interactions to protein stability. Nature, 333(6175), 784–786. https://doi.org/10.1038/333784a0
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., Open Source Drug Discovery Consortium, & Lynn, A. (2014). g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations . Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Lee, H. M., Yu, M. S., Kazmi, S. R., Oh, S. Y., Rhee, K. H., Bae, M. A., Lee, B. H., Shin, D. S., Oh, K. S., & Ceong, H. (2019). Computational determination of hERG-related cardiotoxicity of drug candidates. BMC Bioinformatics, 20, 250.
   PubMed Web of Science ®Google Scholar
• Lennard-Jones, J. E. (1931). Cohesion. Proceedings of the Physical Society, 43(5), 461–482. https://doi.org/10.1088/0959-5309/43/5/301
   Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1–3), 3–25. https://doi.org/10.1016/S0169-409X(96)00423-1
   Web of Science ®Google Scholar
• Lobanov, M., Bogatyreva, N., & Galzitskaya, O. (2008). Radius of gyration as an indicator of protein structure compactness. Molecular Biology, 42(4), 623–628. https://doi.org/10.1134/S0026893308040195
   Web of Science ®Google Scholar
• Lynch, T., & Price, A. (2007). The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. American Family Physician, 76(3), 391–396.
   PubMed Web of Science ®Google Scholar
• Mangal, M., Sagar, P., Singh, H., Raghava, G. P. S., & Agarwal, S. M. (2013). NPACT: Naturally occurring plant-based anti-cancer compound-activity-target database. Nucleic Acids Research, 41(Database issue), D1124–1129. https://doi.org/10.1093/nar/gks1047
   PubMedGoogle Scholar
• Mark, P., & Nilsson, L. (2001). Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. The Journal of Physical Chemistry A, 105(43), 9954–9960. https://doi.org/10.1021/jp003020w
   Web of Science ®Google Scholar
• Mercier, E., Girodat, D., & Wieden, H.-J. (2015). A conserved P-loop anchor limits the structural dynamics that mediate nucleotide dissociation in EF-Tu. Scientific Reports, 5(1), 7677. https://doi.org/10.1038/srep07677
   PubMedGoogle Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Nie, W., Tang, L., Zhang, H., Shao, J., Wang, Y., Chen, L., Li, D., & Guan, X. (2012). Structural analysis of the EGFR TK domain and potential implications for EGFR targeted FR targeted therapy. International Journal of Oncology, 40(6), 1763–1769. https://doi.org/10.3892/ijo.2012.1356
   PubMed Web of Science ®Google Scholar
• O’Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3(1), 33. https://doi.org/10.1186/1758-2946-3-33
   PubMed Web of Science ®Google Scholar
• Padhi, A., Seal, A., & Tripathi, T. (2020). How does arbidol inhibit the novel coronavirus SARS-CoV-2? Atomistic Insights from Molecular Dynamics Simulations. ChemRxiv. https://doi.org/10.26434/chemrxiv.12464576.v1
   Google Scholar
• Peng, Y.-H., Shiao, H.-Y., Tu, C.-H., Liu, P.-M., Hsu, J. T.-A., Amancha, P. K., Wu, J.-S., Coumar, M. S., Chen, C.-H., Wang, S.-Y., Lin, W.-H., Sun, H.-Y., Chao, Y.-S., Lyu, P.-C., Hsieh, H.-P., & Wu, S.-Y. (2013). Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: The role of the DFG motif in the design of epidermal growth factor receptor inhibitors. Journal of Medicinal Chemistry, 56(10), 3889–3903. https://doi.org/10.1021/jm400072p
   PubMed Web of Science ®Google Scholar
• Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2015). PkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• Purohit, R. (2014). Role of ELA region in auto-activation of mutant KIT receptor: A molecular dynamics simulation insight. Journal of Biomolecular Structure & Dynamics, 32(7), 1033–1046. https://doi.org/10.1080/07391102.2013.803264
   PubMed Web of Science ®Google Scholar
• Radchenko, E., Rulev, Y., Safanyaev, A., Palyulin, V., & Zefirov, N. (2017). Computer-aided estimation of the hERG-mediated cardiotoxicity risk of potential drug components. Doklady. Biochemistry and Biophysics, 473(1), 128–131. https://doi.org/10.1134/S1607672917020107
   PubMed Web of Science ®Google Scholar
• Ramos, R. S., Macêdo, W. J. C., Costa, J. S., da Silva, CHTdP., Rosa, J. M. C., da Cruz, J. N., de Oliveira, M. S., de Aguiar Andrade, E. H., Silva, R. B. L. E., & Souto, R. N. P. ( 2020). Potential inhibitors of the enzyme acetylcholinesterase and juvenile hormone with insecticidal activity: Study of the binding mode via docking and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 38(16), 4687–4709. https://doi.org/10.1080/07391102.2019.1688192
   Google Scholar
• Scaltriti, M., Verma, C., Guzman, M., Jimenez, J., Parra, J. L., Pedersen, K., Smith, D. J., Landolfi, S., Ramon y Cajal, S., Arribas, J., & Baselga, J. (2009). Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity. Oncogene, 28(6), 803–814. https://doi.org/10.1038/onc.2008.432
   PubMed Web of Science ®Google Scholar
• Schlessinger, J. (2004). Common and distinct elements in cellular signaling via EGF and FGF receptors. Science (New York, N.Y.), 306(5701), 1506–1507. https://doi.org/10.1126/science.1105396
   PubMed Web of Science ®Google Scholar
• Spoel, D. V. D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. C. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26(16), 1701–1718. https://doi.org/10.1002/jcc.20291
   PubMed Web of Science ®Google Scholar
• Stamos, J., Sliwkowski, M. X., & Eigenbrot, C. (2002). Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. The Journal of Biological Chemistry, 277(48), 46265–46272. https://doi.org/10.1074/jbc.M207135200
   PubMed Web of Science ®Google Scholar
• Su, B.-N., Park, E. J., Nikolic, D., Schunke Vigo, J., Graham, J. G., Cabieses, F., van Breemen, R. B., Fong, H. H. S., Farnsworth, N. R., Pezzuto, J. M., & Kinghorn, A. D. (2003). Isolation and characterization of miscellaneous secondary metabolites of Deprea subtriflora. Journal of Natural Products, 66(8), 1089–1093. https://doi.org/10.1021/np030081n
   PubMed Web of Science ®Google Scholar
• Supandi, Y., & Merdekawati, F. (2018). Silico study of pyrazolylaminoquinazoline toxicity by lazar, protox, and admet predictor. Journal of Applied Pharmaceutical Science, 8(9), 119–129. https://doi.org/10.7324/japs.2018.8918
   Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., & MacKerell, A. D. (2010). CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. Journal of Computational Chemistry, 31(4), 671–690. https://doi.org/10.1002/jcc.21367
   PubMed Web of Science ®Google Scholar
• Wade, R. C., & Goodford, P. J. (1989). The role of hydrogen-bonds in drug binding. Progress in Clinical and Biological Research, 289, 433–444.
   PubMedGoogle Scholar
• Weiss, N., Miller, F., Cazaubon, S., & Couraud, P.-O. (2009). The blood-brain barrier in brain homeostasis and neurological diseases. Biochimica et Biophysica Acta, 1788(4), 842–857. https://doi.org/10.1016/j.bbamem.2008.10.022
   PubMed Web of Science ®Google Scholar
• Wieduwilt, M. J., & Moasser, M. M. (2008). The epidermal growth factor receptor family: Biology driving targeted therapeutics. Cellular and Molecular Life Sciences: CMLS, 65(10), 1566–1584. https://doi.org/10.1007/s00018-008-7440-8
   PubMed Web of Science ®Google Scholar
• Wu, T. S., Hsu, H. C., Wu, P. L., Teng, C. M., & Wu, Y. C. (1998). Rhinacanthin-Q, a naphthoquinone from Rhinacanthus nasutus and its biological activity. Phytochemistry, 49(7), 2001–2003. https://doi.org/10.1016/S0031-9422(98)00425-7
   PubMed Web of Science ®Google Scholar